# A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

> **NCT07559474** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Incyte Corporation** · enrollment: 16 (estimated)

## Conditions studied

- Hepatic Insufficiency
- Liver Diseases

## Interventions

- **DRUG:** INCB123667

## Key facts

- **NCT ID:** NCT07559474
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2027-04-13
- **Final completion:** 2027-04-13
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07559474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07559474, "A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07559474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*